Meningiomas and neurofibromatosis for the oncologist.
The goal of this review is to understand meningioma, one of the most frequent primary intracranial tumors, from an oncologic and neurosurgical point of view. The epidemiology, pathogenesis, cytogenetics, and molecular genetics are presented. The operative therapeutic possibilities, the recurrence rates in relation to the intracranial tumor localization, and the place of adjunctive therapies is discussed. Although the emphasis of this review is on developments in the past year, some historical references are provided.
Schrell
U M
UM
Neurochirurgische Klinik, Universitat Erlangen-Nürnberg, Germany.
Fahlbusch
R
R
Adams
E F
EF
D006133:Growth Substances / Q000502:physiology; D006801:Humans; D008577:Meningeal Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D008579:Meningioma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D009364:Neoplasm Recurrence, Local; D009456:Neurofibromatosis 1 / Q000628:therapy*; D016518:Neurofibromatosis 2 / Q000628:therapy*; D009857:Oncogenes
D006133:Growth Substances